Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Squamous Cell Carcinoma of Head and Neck × durvalumab × Clear all

Phase

Phase 2 12 Phase 1 10 Phase 1/2 5 Phase EARLY_PHASE1 2 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 29 Lung Neoplasms 9 Small Cell Lung Carcinoma 7 Biliary Tract Neoplasms 7 Carcinoma, Hepatocellular 5 Urinary Bladder Neoplasms 4 Liver Neoplasms 4 Carcinoma 4 Small Cell Lung Carcinoma Extensive Disease 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Gallbladder Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urothelial Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Pancoast Syndrome 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Small Cell Lung Carcinoma NSCLC 1 Non Small Cell Lung Cancer NSCLC 1 Non - Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1

Interventions

Cisplatin 42 Radiotherapy 33 Cetuximab 25 Fluorouracil 22 pembrolizumab 16 Carboplatin 14 Docetaxel 12 Paclitaxel 8 Radiotherapy, Intensity-Modulated 6 Nivolumab 6 Methotrexate 6 Drug Therapy 6 Surgical Procedures, Operative 4 Magnetic Resonance Spectroscopy 4 Chemotherapy, Adjuvant 4 Taxes 3 toripalimab 2 nimotuzumab 2 lenvatinib 2 epacadostat 2 dehydroftorafur 2 camrelizumab 2 avelumab 2 Specimen Handling 2 Radiotherapy, Conformal 2 Radiation 2 Porfiromycin 2 Platinum 2 Panitumumab 2 Nimorazole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03673735 2021-05-10

ADHERE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡